These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 30986824)
1. Diminished OPA1 expression and impaired mitochondrial morphology and homeostasis in Aprataxin-deficient cells. Zheng J; Croteau DL; Bohr VA; Akbari M Nucleic Acids Res; 2019 May; 47(8):4086-4110. PubMed ID: 30986824 [TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene. Ababneh NA; Al-Kurdi B; Ali D; Abuarqoub D; Barham R; Alzibdeh AM; Khanfar AN; Altantawi AM; Ryalat AT; Sharrack B; Awidi A Stem Cell Res; 2020 Oct; 48():101925. PubMed ID: 32769066 [TBL] [Abstract][Full Text] [Related]
3. Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway. Garcia-Diaz B; Barca E; Balreira A; Lopez LC; Tadesse S; Krishna S; Naini A; Mariotti C; Castellotti B; Quinzii CM Hum Mol Genet; 2015 Aug; 24(16):4516-29. PubMed ID: 25976310 [TBL] [Abstract][Full Text] [Related]
4. Molecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease. Schellenberg MJ; Tumbale PP; Williams RS Prog Biophys Mol Biol; 2015 Mar; 117(2-3):157-165. PubMed ID: 25637650 [TBL] [Abstract][Full Text] [Related]
5. Slow mitochondrial repair of 5'-AMP renders mtDNA susceptible to damage in APTX deficient cells. Akbari M; Sykora P; Bohr VA Sci Rep; 2015 Aug; 5():12876. PubMed ID: 26256098 [TBL] [Abstract][Full Text] [Related]
6. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia/ataxia with oculomotor apraxia 1. Tada M; Yokoseki A; Sato T; Makifuchi T; Onodera O Adv Exp Med Biol; 2010; 685():21-33. PubMed ID: 20687492 [TBL] [Abstract][Full Text] [Related]
7. Ataxia with Ocular Apraxia Type 1 (AOA1) (APTX, W279* Mutation): Neurological, Neuropsychological, and Molecular Outlining of a Heterogenous Phenotype in Four Colombian Siblings. Aguillon D; Vasquez D; Madrigal L; Moreno S; Hernández D; Isaza-Ruget M; Lopez JJ; Landires I; Nuñez-Samudio V; Restrepo CM; Vidal OM; Vélez JI; Arcos-Holzinger M; Lopera F; Arcos-Burgos M Mol Neurobiol; 2022 Jun; 59(6):3845-3858. PubMed ID: 35420381 [TBL] [Abstract][Full Text] [Related]
8. The DNA repair enzyme, aprataxin, plays a role in innate immune signaling. Madsen HB; Pease LI; Scanlan RL; Akbari M; Rasmussen LJ; Shanley DP; Bohr VA Front Aging Neurosci; 2023; 15():1290681. PubMed ID: 38161589 [TBL] [Abstract][Full Text] [Related]
10. Complementation of aprataxin deficiency by base excision repair enzymes in mitochondrial extracts. Çaglayan M; Prasad R; Krasich R; Longley MJ; Kadoda K; Tsuda M; Sasanuma H; Takeda S; Tano K; Copeland WC; Wilson SH Nucleic Acids Res; 2017 Sep; 45(17):10079-10088. PubMed ID: 28973450 [TBL] [Abstract][Full Text] [Related]
11. Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. Harris JL; Jakob B; Taucher-Scholz G; Dianov GL; Becherel OJ; Lavin MF Hum Mol Genet; 2009 Nov; 18(21):4102-17. PubMed ID: 19643912 [TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the aprataxin (APTX) gene in an Iranian individual suffering early-onset ataxia with oculomotor apraxia type 1(AOA1) disease. Nouri N; Nouri N; Aryani O; Kamalidehghan B; Sedghi M; Houshmand M Iran Biomed J; 2012; 16(4):223-5. PubMed ID: 23183622 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia. Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166 [TBL] [Abstract][Full Text] [Related]
14. DNA single-strand break repair is impaired in aprataxin-related ataxia. Hirano M; Yamamoto A; Mori T; Lan L; Iwamoto TA; Aoki M; Shimada K; Furiya Y; Kariya S; Asai H; Yasui A; Nishiwaki T; Imoto K; Kobayashi N; Kiriyama T; Nagata T; Konishi N; Itoyama Y; Ueno S Ann Neurol; 2007 Feb; 61(2):162-74. PubMed ID: 17315206 [TBL] [Abstract][Full Text] [Related]
15. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Ahel I; Rass U; El-Khamisy SF; Katyal S; Clements PM; McKinnon PJ; Caldecott KW; West SC Nature; 2006 Oct; 443(7112):713-6. PubMed ID: 16964241 [TBL] [Abstract][Full Text] [Related]
16. A novel nonsense mutation in the APTX gene associated with delayed DNA single-strand break removal fails to enhance sensitivity to different genotoxic agents. Crimella C; Cantoni O; Guidarelli A; Vantaggiato C; Martinuzzi A; Fiorani M; Azzolini C; Orso G; Bresolin N; Bassi MT Hum Mutat; 2011 Apr; 32(4):E2118-33. PubMed ID: 21412945 [TBL] [Abstract][Full Text] [Related]
17. Complementation of aprataxin deficiency by base excision repair enzymes. Çağlayan M; Horton JK; Prasad R; Wilson SH Nucleic Acids Res; 2015 Feb; 43(4):2271-81. PubMed ID: 25662216 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin. Asai H; Hirano M; Shimada K; Kiriyama T; Furiya Y; Ikeda M; Iwamoto T; Mori T; Nishinaka K; Konishi N; Udaka F; Ueno S Hum Mol Genet; 2009 Oct; 18(19):3533-43. PubMed ID: 19561170 [TBL] [Abstract][Full Text] [Related]
19. Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1. Renaud M; Moreira MC; Ben Monga B; Rodriguez D; Debs R; Charles P; Chaouch M; Ferrat F; Laurencin C; Vercueil L; Mallaret M; M'Zahem A; Pacha LA; Tazir M; Tilikete C; Ollagnon E; Ochsner F; Kuntzer T; Jung HH; Beis JM; Netter JC; Djamshidian A; Bower M; Bottani A; Walsh R; Murphy S; Reiley T; Bieth É; Roelens F; Poll-The BT; Lourenço CM; Jardim LB; Straussberg R; Landrieu P; Roze E; Thobois S; Pouget J; Guissart C; Goizet C; Dürr A; Tranchant C; Koenig M; Anheim M JAMA Neurol; 2018 Apr; 75(4):495-502. PubMed ID: 29356829 [TBL] [Abstract][Full Text] [Related]